Meeting the challenge of the evolving R&D paradigm: What role for CROs?

American Pharmaceutical Outsourcing

Volumn 5, Issue 2, 2004, Pages 44-50

  Milne, Christopher Paul ^a   Paquette, Cherie ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; AUSTRALIA; BIOTECHNOLOGY; CLINICAL RESEARCH; CLINICAL STUDY; DRUG INFORMATION; DRUG LEGISLATION; DRUG MARKETING; DRUG RESEARCH; HEALTH SERVICE; HUMAN; INTERNET; OUTPATIENT DEPARTMENT; PATIENT SELECTION; PHARMACOGENOMICS; POSTMARKETING SURVEILLANCE; PRIVATE PRACTICE; REIMBURSEMENT; SCORING SYSTEM; SOUTHEAST ASIA; UNITED STATES;

EID: 1942467824     PISSN: 15296318     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. R&D Outsource Spending to Rise 14% a Year; CROs Will Gain the Most- Study. Pink Sheet, 15 December 2003;65(50):30.
2. Schaub, W. Searching for a CRO-Can the Internet help? Applied Clinical Trials, April 2003;12(4):45-8.
3. Pace of CRO Acquisitions Accelerates. CenterWatch, July 2002;9(7):1-8.
4. Pace of CRO Acquisitions Accelerates. CenterWatch, July 2002;9(7):1-8.
5. Smith, N. The Strains of Pharming it Out. Scrip Magazine, July/August 2002:32-3.
6. Milne, C-P. Pediatric Research: Coming of Age in the New Millennium. American Journal of Therapeutics, September 1999;6(5):263-82.
7. Milne, C-P. The Pediatric Studies Incentive: Equal Medicines for All [white paper], April 2001. Available from Tufts Center for the Study of Drug Development, Tufts University, Boston, MA.
8. Tufts Center for the Study of Drug Development. CROs Provide Gateway to Worldwide Clinical Trial Recruitment Efforts. Tufts CSDD Impact Report (Kaitin, KI, editor) July/August 2003;5(4):1-4.
9. Bodenheimer, T. Uneasy Alliance: Clinical Investigators and the Pharmaceutical Industry. New England Journal of Medicine, 18 May 2000;342(20):1539-44.
10. Tufts Center for the Study of Drug Development. CROs Provide Gateway to Worldwide Clinical Trial Recruitment Efforts. Tufts CSDD Impact Report (Kaitin, KI, editor) July/August 2003;5(4):1-4.
11. Jern, D. & Bohlin, N. Strategic Implications of the Biological Revolution. Scrip Magazine, December 2001:19-21.
12. Bleicher, P. Technology and the Internet in Clinical Trials [guest lecture]. Postgraduate Course in Clinical Care Research, Tufts Medical School, 20 November 2003.
13. Fritsch, S. Moving Towards Personal Medicines. Scrip Magazine, September 2002:25-28.
14. The New CRO Price Wars. CenterWatch, September 2003;10(9):1-14.
15. Pharma Pipelines Filling, Firms Say; New Fear is "Bottleneck" in Early Stage. Pink Sheet, 21 April 2003;65(16 ):20-21.
16. Taylor, J.E. Meeting the Challenges of the Evolving Outsourcing Paradigm: the Sponsor's View [presentation]. Drug Information Association Annual Meeting, San Antonio, TX, 16 June 2003.
17. Vogel, J.R. Meeting the Challenges of the Evolving R&D Paradigm: What Role for CROs? [presentation]. Drug Information Association Annual Meeting, San Antonio, TX, 16 June 2003.